Related Experiment Video
Updated: Jan 15, 2026
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
Factors Related to Blood Transfusions in Pregnant Women Undergoing Caesarean Sections: A 20-year Retrospective Study
Saifon Chawanpaiboon1, Vitaya Titapant1, Julaporn Pooliam2
1Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Background:
The rising rates of caesarean section (CS) globally have been associated with an increase in maternal complications, including the need for blood transfusions. Maternal anaemia, uterine atony, and placenta-related disorders contribute significantly to haemorrhagic complications during CS. This study aimed to evaluate the factors associated with blood transfusions in pregnant women undergoing CS at Siriraj Hospital over a 20-year period.
Methods:
This large, retrospective study enrolled 1277 pregnant women who underwent CS and received blood transfusions at Siriraj Hospital between January 1999 and December 2019. Demographic data, baseline haematocrit, underlying diseases, indications for CS, and relevant neonatal details were retrieved from medical records. Statistical analyses were performed to identify factors associated with increased transfusion rates, with a focus on maternal anaemia, uterine atony, placenta previa, and placenta accreta spectrum.
Results:
Over the 20-year period, the rate of CS increased from 1.9% in 2002 to 48.5% in 2017. Concurrently, the need for blood transfusions also rose, with the highest transfusion rate recorded at 3.2% in 2019. The most common indications for transfusion were uterine atony (22.6%), placenta previa, and anaemia. Women with placenta accreta spectrum had a 6-fold higher likelihood of transfusion (aOR 6.530, 95% CI 4.056-10.510; P < 0.001), and those with uterine atony were 3.5 times (aOR 3.612, 95% CI 2.599-5.019; P < 0.001) more likely to require transfusions. Anaemic mothers also demonstrated a significantly higher risk for transfusion.
Conclusion:
Blood transfusion risk in CS is strongly linked to placenta accreta spectrum, uterine atony, and maternal anaemia. Early identification of high-risk pregnancies and optimization of antenatal care are essential for reducing transfusion needs and improving maternal outcomes.
Clinical Trial Registration:
Clinical trial number: TCTR20200505001 (Registered on 5 May 2020).
More Related Videos
09:52Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye
Published on: September 5, 2011
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Related Concept Videos
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
01:19Rh Blood Group
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:15Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:28Factors affecting Blood pressure
Physiological Factors: